Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Raúl R. Rodrigues-Díez"'
Autor:
Lucia Tejedor-Santamaria, Jose Luis Morgado-Pascual, Laura Marquez-Exposito, Beatriz Suarez-Alvarez, Raul R. Rodrigues-Diez, Antonio Tejera-Muñoz, Vanessa Marchant, Sergio Mezzano, Carlos Lopez-Larrea, Anna Sola, Gema Maria Fernandez-Juarez, Alberto Ortiz, Sandra Rayego-Mateos, Marta Ruiz-Ortega
Publikováno v:
Pharmaceuticals, Vol 15, Iss 2, p 121 (2022)
Crescentic glomerulonephritis is a devastating autoimmune disease that without early and properly treatment may rapidly progress to end-stage renal disease and death. Current immunosuppressive treatment provides limited efficacy and an important burd
Externí odkaz:
https://doaj.org/article/5f033fe79f654d77a5d276372d885471
Autor:
Laura Marquez-Exposito, Carolina Lavoz, Raul R. Rodrigues-Diez, Sandra Rayego-Mateos, Macarena Orejudo, Elena Cantero-Navarro, Alberto Ortiz, Jesús Egido, Rafael Selgas, Sergio Mezzano, Marta Ruiz-Ortega
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Chronic kidney disease (CKD) is emerging as an important health problem due to the increase number of CKD patients and the absence of an effective curative treatment. Gremlin has been proposed as a novel therapeutic target for renal inflammatory dise
Externí odkaz:
https://doaj.org/article/718d5cae0796436995b14c5c1f61b494
Autor:
Carolina Lavoz, Raul R. Rodrigues-Diez, Anita Plaza, Daniel Carpio, Jesús Egido, Marta Ruiz-Ortega, Sergio Mezzano
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2, p 302 (2020)
The absence of optimal treatments for Diabetic Nephropathy (DN) highlights the importance of the search for novel therapeutic targets. The vascular endothelial growth factor receptor 2 (VEGFR2) pathway is activated in experimental and human DN, but t
Externí odkaz:
https://doaj.org/article/e2f5a58cb17d465ebd2555886286d1c3